MO36-2 Updated analysis from a phase II study on the efficacy of nivolumab in patients with cancer of unknown primary (NivoCUP)

This article has no abstract
Epistemonikos ID: 453aae0e338d3f3cbb30600490328f7245e1f3ef
First added on: Feb 17, 2025